SMAD2 and neoplasm: A recent study by Liu et al. [13], showed that miR-140-5p was down-regulated in Wilms’ tumor and suppressed tumor progression via modulating TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways.